1
Lghoul-Oulad Said, Fouzia, Hek, Karin, Flinterman, Linda E., Herings, Ron M. C., Warle-van Herwaarden, Margaretha F., de Bie, Sandra, Valkhoff, Vera E., Alsma, Jelmer, Mosseveld, Mees, Vanrolleghem, Ann M., Stricker, Bruno H. C. H., Sturkenboom, Miriam C. J. M., De Smet, Peter A. G. M., van den Bemt, Patricia M. L. A.
Veröffentlicht in: Lghoul-Oulad Said , F , Hek , K , Flinterman , L E , Herings , R M C , Warle-van Herwaarden , M F , de Bie , S , Valkhoff , V E , Alsma , J , Mosseveld , M , Vanrolleghem , A M , Stricker , B H C H , Sturkenboom , M C J M , De Smet , P A G M & van den Bemt , P M L A 2020 , ' Prevalence and incidence rate of hospital admissions related to medication between 2008 and 2013 in The Netherlands ' , Pharmacoepidemiology and Drug Safety , no. 12 , pp. 1659-1668 . https://doi.org/10.1002/pds.5122;
2020
Veröffentlicht in: Lghoul-Oulad Said , F , Hek , K , Flinterman , L E , Herings , R M C , Warle-van Herwaarden , M F , de Bie , S , Valkhoff , V E , Alsma , J , Mosseveld , M , Vanrolleghem , A M , Stricker , B H C H , Sturkenboom , M C J M , De Smet , P A G M & van den Bemt , P M L A 2020 , ' Prevalence and incidence rate of hospital admissions related to medication between 2008 and 2013 in The Netherlands ' , Pharmacoepidemiology and Drug Safety , no. 12 , pp. 1659-1668 . https://doi.org/10.1002/pds.5122;
2020
2
3
Fens, T., van der Pol, S., Kocks, Janwillem W.H., Postma, Maarten J., van Boven, Job F.M.
Veröffentlicht in: Fens , T , van der Pol , S , Kocks , J W H , Postma , M J & van Boven , J F M 2019 , ' Economic Impact of Reducing Inappropriate Inhaled Corticosteroids Use in Patients With Chronic Obstructive Pulmonary Disease : ISPOR’s guidance on budget impact in practice ' , Value in Health , vol. 22 , no. 10 , pp. 1092-1101 . https://doi.org/10.1016/j.jval.2019.05.006;
2019
Veröffentlicht in: Fens , T , van der Pol , S , Kocks , J W H , Postma , M J & van Boven , J F M 2019 , ' Economic Impact of Reducing Inappropriate Inhaled Corticosteroids Use in Patients With Chronic Obstructive Pulmonary Disease : ISPOR’s guidance on budget impact in practice ' , Value in Health , vol. 22 , no. 10 , pp. 1092-1101 . https://doi.org/10.1016/j.jval.2019.05.006;
2019
4
5
6
7
8